PHARMACEUTICAL PRESS REVIEW from 18 to 20 September of AboutPharmaRosario Bifulco is the new President of Pierrel
(Libero Mercat page 13, Bloomberg Finance & Mercat page 7, Il Sole 24 Ore Finance & Mercat page 45 – 20 September 2007)
Pierrel's Board of Directors has appointed Rosario Bifulco, former number one of Lottomatica, as President of the company in which he is a shareholder with 6,27% and confirmed Canio Mazzaro as Chief Executive Officer. The company also announced the purchase of 100% from Hungarian Goodwill Research, active in pharmaceutical contract research in various Eastern European countries, for a sum of 3.3 million euro.
http://www.aboutpharma.it/notizia.asp?id=14335
Tomorrow strike of family doctors. Lombardy excluded
(la Repubblica: page 20 – 20 September 2007)
On September 21, the strike of General Medicine and Primary Care doctors is expected throughout the country, excluding Lombardy where they will cross arms on September 27 and 28.
http://www.aboutpharma.it/notizia.asp?id=14334
“Research institutions, delegation is law”
(Il Sole 24 Ore: page 29, Il Messagger page 14 – 20 September 2007)
The Senate has approved the law that gives autonomy to research, guaranteeing institutions the right to elect their own governing bodies. The document also provides for new powers of commissariation, the heads of the entities will be canceled if the Government's 'objectives' are not achieved, but also in cases of 'proven operating difficulties' or 'statutory changes concerning the mission and structure'.
http://www.aboutpharma.it/notizia.asp?id=14333
“5.4% drop in pharmaceutical spending”
(Libero Mercat page 14 – 20 September 2007)
Pharmaceutical expenditure in the month of July was 5.4% less than in the same period of 2006, confirming the overall trend of -8.9% in the first half of 2007. According to Federfarma data, the reduction in spending is more contained in this month compared to the first 6 months of the year because the comparison is with July of last year, when the effects of the selective cuts in the prices of medicines introduced by AIFA began to manifest themselves and because in July of this year there was a considerable increase in the number of recipes (+9.4%)
http://www.aboutpharma.it/notizia.asp?id=14332
“Crack Healthcare, bailout plan”
